Hydrochlorothiazide
- Product NDC
- 71610-014
- 11-digit product format
- 716100014
- Labeler code
- 71610
- Product ID
- 71610-014_2c278b34-9004-4bae-a43d-ee454d87b9ba
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA083177
- Marketing category
- ANDA
- Marketing start
- 2017-06-08
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-014 | HYDROCHLOROTHIAZIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | Legacy NDC | 20190424_27e9e65d-d6f5-40e6-899e-cb033a171291.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-014-15 | 71610001415 | 15 TABLET in 1 BOTTLE (71610-014-15) | 15 tablet | 2017-12-01 | 0000-00-00 | No | No | Current |
| 71610-014-30 | 71610001430 | 30 TABLET in 1 BOTTLE (71610-014-30) | 30 tablet | 2017-12-01 | 0000-00-00 | No | No | Current |
| 71610-014-45 | 71610001445 | 45 TABLET in 1 BOTTLE (71610-014-45) | 45 tablet | 2017-12-01 | 0000-00-00 | No | No | Current |
| 71610-014-53 | 71610001453 | 60 TABLET in 1 BOTTLE (71610-014-53) | 60 tablet | 2018-01-08 | 0000-00-00 | No | No | Current |
| 71610-014-60 | 71610001460 | 90 TABLET in 1 BOTTLE (71610-014-60) | 90 tablet | 2017-12-01 | 0000-00-00 | No | No | Current |